Samsung Electronics agreed to acquire US-based digital health company Xealth, as it seeks to integrate more advanced tracking features and medical information from hospitals into its wearables and other connected devices.

Xealth provides a platform that integrates multiple digital health tools into a single interface, enabling “real-time patient monitoring, continuous engagement and streamlined clinical workflows”.

It operates a control hub that allows health systems to control, manage and analyse patient data across various sources. The company currently partners with major US hospital networks including Advocate Health and Banner Health.

Samsung stated the acquisition will enhance its health platform by linking data from its wearables and connected devices with hospital records, offering a unified view of patient health. The integration is expected to improve preventative, personalised care and support clinical decision making.

“Customer health data from wearables can fill in context that is missing to hospitals and bring more data analysis possibilities that were not available just with clinical records,” explained Xealth CEO Mike McSherry.

The deal will extend Samsung’s digital health reach to more than 500 hospitals and more than 70 health solution partners, strengthening its push into the medical sector.

TM Roh, president and acting head of the Device eXperience (DX) division at Samsung Electronics hailed the acquisition as “an anchor” in the company’s efforts to bolster health systems through “open collaboration with industry leaders”.

The South Korean vendor added the latest move complements heavy investment in wearable sensor technologies to enable its device ecosystem to play a greater role in personalised healthcare. The company aims to close the gap between consumer wellness data and clinical care to unify fragmented health information.

Financial terms were not disclosed and the acquisition remains subject to regulatory approvals, which Samsung expects will be concluded in 2025.